A supply shortage of the company’s nasal testosterone replacement therapy will impact sales estima... Read More
After completing a new financing round, specialty pharma company Acerus Pharmaceuticals (Acerus Phar... Read More
Following the company’s fourth quarter results, Mackie Research Capital analyst André Uddin r... Read More
Specialty pharma company Acerus Pharmaceuticals (Acerus Pharmaceuticals Stock Quote, Chart TSX:ASP) ... Read More
Following what he describes as positive results from a Phase 1 study, Mackie Research Capital analys... Read More
Specialty pharma company Acerus Pharmaceuticals (TSX:ASP) produced soft results in its third quarter... Read More
Share
